Pamela Esposito

Affiliations

  • Chief Business Officer at Replimune Group Inc. (REPL), 2023-09-14
  • Director at Kymera Therapeutics Inc. (KYMR), 2023-06-20
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
REPL $20.00 300 Officer 263,436 2023-09-12 Filing
REPL $20.01 5,358 Officer 263,436 2023-09-11 Filing
REPL $20.01 18,600 Officer 263,436 2023-08-22 Filing
REPL $20.00 1,400 Officer 263,436 2023-08-11 Filing
REPL $21.12 2,077 Officer 263,436 2023-07-10 Filing